Table 2 Characteristics at study enrollment of HIV-infected children not receiving ART
From: Barriers to the care of HIV-infected children in rural Zambia: a cross-sectional analysis
| Â | Total (n = 138) | Children not eligible for ARTc (n = 53) | Children eligible for ART at study enrollment (n = 79) |
|---|---|---|---|
Median age (yrs) (IQR) a | 3.3 (1.8, 6.7) | 3.6 (2.5, 6.7) | 2.3 (1.3, 6.7) |
Male (%) | 55 (40) | 20 (38) | 34 (43) |
Length of time (months) since enrolling in ART clinic | 3.2 (0.5, 10.1) | 3.8 (0.2, 11.7) | 2.8 (0.4, 9.0) |
Median WAZ (IQR) (n = 120) a,b | -2.2 (-3.2, -1.3) | -2.1 (-2.7, -1.0) | -2.4 (-3.5,-1.6) |
   WAZ <-2 | 66 (55) | 25 (53) | 41 (59) |
   WAZ ≥-2 | 54 (45) | 22 (47) | 28 (41) |
Median CD4 + T cell % (IQR) (n = 122) a | 20.7 (16.0, 30.0) | 29.6 (23.2, 36.9) | 17.4 (12.1, 21.1) |
Median CD4 + T cell count (IQR) (n = 126) a | 815 (455, 1372) | 980 (578, 1434) | 735 (377, 1287) |
Severe immunodeficiency a,d | 47 (37) | 0 (0.0) | 47 (64) |
Median total lymphocyte count (IQR) (n = 73) | 4266 (2238, 7025) | 3289 (2179, 4847) | 4464 (2328, 7236) |
Median hemoglobin (IQR) (n = 110) a | 10.5 (9.2,11.6) | 11.3 (9.8,11.7) | 10.1 (8.8, 11.3) |
   Hemoglobin <8 gm/dL | 6 (5) | 1 (3) | 5 (7) |
   Hemoglobin ≥8 gm/dL | 104 (95) | 36 (97) | 68 (93) |
WHO stage (n = 101) a | Â | Â | Â |
   1 | 17 (16) | 11 (34) | 5 (7) |
   2 | 33 (32) | 21 (66) | 10 (14) |
   3 | 38 (37) | 0 (0) | 38 (55) |
   4 | 16 (15) | 0 (0) | 16 (23) |